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Clinical
Head and neck cancer is relatively uncommon. They
constitute approximately 3% of all cancers, with nearly
7000 new cases annually in the UK, giving an incidence
of 12 per 100 000 (larynx, 4.5; oral cavity, 3.5; pharynx,
2.5; others, 1.5). The importance of head and neck
cancer lies in the heterogeneity of its constituent
parts, the potential for cure and the need to minimize
functional impairment.
The major risk factors for developing neck cancer are
smoking and alcohol consumption. Diet lacking in cer-
tain elements, particularly vitamins A and C, may
predispose an individual to develop oral cancer.
In many head and neck sites of cancer there is no
consensus about ‘optimum’ treatment, thus highlighting
the necessity for multidisciplinary assessment and man-
agement of these patients. The treatment options are
surgery (conventional, laser and reconstructive), radio-
therapy (brachytherapy and teletherapy), chemotherapy,
combined modality and palliative care.
Objectives
Nasopharynx and oral cavity
(1) Staging of proven malignant tumours
Local extent of the primary tumour (T)
Nodal involvement (N)
Metastases (M)
(2) Detection of occult primary tumours










(1) To evaluate mass lesions
Diﬀerentiate between benign and malignant
tumours
Surgical treatment planning
Diﬀerentiate between an extrinsic para-
pharyngeal space mass and an intrinsic parotid
mass
Paranasal sinuses
(1) Staging the primary tumour







In head and neck cancer the principle role of any
imaging modality is to identify the deep infiltration of
tumour, and the presence of metastases, particularly
lymphadenopathy. Mucosal changes can often be
evaluated by direct inspection.
Whilst Magnetic Resonance Imaging (MRI) is recog-
nized as having greater tissue discrimination than other
imaging modalities, there is still a significant problem
with image degradation due to motion artefact; despite
the availability of fast imaging sequences.
In the pharynx the nasopharynx is subject to the least
motion, and in assessing tumours of the nasopharynx
MRI is accepted as the imaging modality of choice; the
better tissue contrast and multiplanar facility combining
to improve the accuracy of staging compared with
computed tomography (CT).
Oral cavity/oropharynx
In assessing tumours of the oral cavity and oropharynx,
motion is a problem, and CT and MRI are considered
complementary investigations. However, with appropri-
ate patient selection the staging of oral cavity and
oropharyngeal tumours can be achieved by MRI alone,
and in patients with tumours at certain sites, for
example, the posterior third of the tongue, it is more
accurate than CT, enabling more precise radiotherapy
and surgical treatment planning.
These statements also apply to the patient with recur-
rent tumour, who is potentially suitable for salvage
surgery.
Patients with large oral cavity tumours, and excessive
salivation are usually best imaged by CT. Chronic
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obstructive pulmonary disease often co-exists in these
patients.
Salivary glands
Parotid gland. Whilst at present CT is the mainstay
for evaluation of glandular and peri-glandular masses,
MRI can readily distinguish between lesions in the deep
lobe of the parotid gland and those in the para-
pharyngeal space, but more significantly, the facial nerve
is often seen distal to the stylomastoid foramen, thereby
allowing a more accurate assessment of its relationship
to a mass lesion. A disadvantage of MRI is the relatively
poor detection of intra-glandular calcification or calculi
within the salivary ducts. CT is, therefore, preferred to
MRI when a mass is thought to be inflammatory.
Submandibular/sublingual glands. Mass lesions can be
assessed by MRI with the multiplanar facility providing
information about the relationship with the mass to
the floor of the mouth and the parapharyngeal and
masticator spaces.
Submental and submandibular lymphadenopathy is
readily identified.
Paranasal sinuses/larynx/hypopharynx
CT and MRI are complementary investigations. The
choice of imaging modality will often depend on the
patient’s status and ability to co-operate.
The advantage of CT is that it is quicker and more
readily available than MRI. It is also more sensitive to
cortical bone invasion.
Currently, CT is used for radiotherapy treatment
planning.
Technique
MRI of the extracranial head and neck structures re-
quires good patient co-operation. A high proportion of
the patients have poor oral hygiene and are often
alcohol abusers. The tumour itself often results in in-
creased secretions and salivation and there is often
associated airways disease. Coughing, swallowing and
dyspnoea all predispose to image degradation due to
motion artefact.
All patients should have an explanation of the
procedure given to them by the radiographer together
with reminders during the procedure not to cough or
swallow. Data are acquired during quiet respiration.
An appropriate coil should be chosen to cover the
area of interest and imaging should be undertaken in at
least two orthogonal planes. Spin echo (SE) sequences
are less sensitive than gradient echo (GE) to motion and
susceptibility artefacts. Pre-contrast T1-weighted se-
quences are necessary for the assessment of medullary
bone involvement.
With fast spin echo sequences tumour and brain can
have similar signal intensity and i.v. contrast medium is
usually required to distinguish tumour from normal
brain. Contrast medium is also required for the detec-
tion of perincural/intracranial extension.
Lymph nodes can be assessed with: (a) T1-weighted;
(b) fat-suppressed T2-weighted or Gd-enhanced T1-
weighted; or (c) STIR sequences.
Flow-sensitive sequences and/or MR angiography are
important complementary studies to assess the relation-
ship of tumour to the carotid sheath, or to identify the
vessels in the skull base.
There are some key points to remember in interpret-
ing the MR images and these are:
(1) Retained fluid secretions in the paranasal sinuses
have a higher signal than tumour on T2-weighted
scans and do not enhance
(2) Inflamed mucosa enhances more than tumour
(3) Highly cellular tumour is generally of low/
intermediate signal intensity on T1–T2-weighted
sequences
(4) Serous/myxoid tumour elements produce increased
signal on T2-weighted sequences, e.g. in adenocystic
carcinoma, necrosis in squamous cell carcinoma
(5) Loss of the low signal intensity cortical line and low
marrow signal intensity on T1-weighted sequences
implies bone invasion
(6) Normal mucosa, lymphoid tissue and vessels enhance
and can mask tumour, and limit tumour boundary
definition
Reassessment
Patients will usually have a reassessment scan to: (a)
assess the response to the treatment; (b) to identify
tumour recurrence; or (c) to assess the complications of
treatment.
Ideally, patients should be scanned in a similar
fashion to the original study and i.v. contrast medium is
required, particularly when diﬀerentiating between
treatment eﬀect and tumour recurrence. The distinction
between the two is often diﬃcult.
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